Research Article10.1016/j.vaccine.2026.128692Immunogenicity of 2 versus 3 dose HPV vaccination by HIV infection status in Eswatini.Jul 01, 2026VaccineHarriet Nuwagaba-Biribonwoha + 13 more +13CiteListenSave
Research Article10.1016/j.vaccine.2026.128634Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.Jun 11, 2026VaccineYun Sang Tang + 9 more +9CiteListenSave
Research Article10.1016/j.vaccine.2026.128636Tailoring the Australian vaccine barriers assessment tool (VBAT) for Aotearoa New Zealand: Using a local equity approach.Jun 11, 2026VaccineNikki Turner + 7 more +7CiteListenSave
Research Article10.1016/j.vaccine.2026.128721Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.May 19, 2026VaccineCharlene A Caburnay + 6 more +6CiteListenSave
Research Article10.1016/j.vaccine.2026.128710Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment.May 14, 2026VaccineMargie Danchin + 7 more +7CiteListenSave
Research Article10.1016/j.vaccine.2026.128688Modeling optimal deployment strategies for Nipah vaccines and monoclonal antibodies.May 12, 2026VaccineOscar Cortes-Azuero + 8 more +8CiteListenSave
Research Article10.1016/j.vaccine.2026.128665Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.May 04, 2026VaccineYu-Sheng Shen + 7 more +7CiteListenSave
Research Article10.1016/j.vaccine.2026.128490Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamsters.Apr 19, 2026VaccineKelsey Briggs + 23 more +23CiteListenSave
Research Article10.1016/j.vaccine.2026.128345A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-85years of age.Apr 01, 2026VaccineMatthew Davis + 14 more +14CiteListenSave
Research Article10.1016/j.vaccine.2026.128380Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.Apr 01, 2026VaccineAaron Hudson + 29 more +29CiteListenSave